Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. •• Pannu AK. Methotrexate overdose in clinical practice. Curr Drug Metab. 2019;20:714–9. https://doi.org/10.2174/1389200220666190806140844Provides detailed information concerning pharmacokinetics and pharmacodynamics.
2. Brown PM, Pratt AG, Isaacs JD. Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers. Nat Rev Rheumatol. 2016;12:731–42. https://doi.org/10.1038/nrrheum.2016.175.
3. Hoekstra M, Haagsma C, Neef C, Proost J, Knuif A, van de Laar M. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis. J Rheumatol. 2004;31:645–8 Retrieved from http://www.jrheum.org/content/31/4/645.
4. Augmente D, Santos Buelga D, Lukas JC, Gomez P, Torres A, Jose Garcia M. Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia. Clin Pharmacokinet. 2006;45:1227–38. https://doi.org/10.2165/00003088-200645120-00007.
5. Medellin-Garibay SE, Hernandez-Villa N, Correa-Gonzalez LC, Morales-Barragan MN, Valero-Rivera KP, Resendiz-Galvan JE, et al. Population pharmacokinetics of methotrexate in Mexican pediatric patients with acute lymphoblastic leukemia. Cancer Chemother Pharmacol. 2020;85:21–31. https://doi.org/10.1007/s00280-019-03977-1.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献